MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Senktide

CAS No. : 106128-89-6

MCE 站：Senktide

产品活性：Senktide 是一种速激肽 NK₃ 受体激动剂。

研究领域：GPCR/G Protein  |  Neuronal Signaling

作用靶点：Neurokinin Receptor

In Vitro: The selective NK₃ receptor agonist Senktide excites 24 of 31 dopaminergic neurons in the substantia nigra pars compacta in a concentration-dependent manner. The effective concentration range is between 3 to 3000 nm. The mean EC₅₀ for Senktide is 41.2±9 nm (n=5).

In Vivo: I.c.v. injection of Senktide causes a dose-dependent increase in total distance traveled (F_6,72=6.344, P<0.001). This increase reaches statistical significance compare to the vehicle-treated group at 0.06 nmol and higher. The Senktide-induced increase in locomotor activity brought about by 0.1 nmol of Senktide is significantly and dose-dependently decreased by the tachykinin NK₃ receptor antagonists talnetant at 30 mg/kg and SB222200 at 30 mg/kg, but not by osanetant, when tested in parallel in a single experiment (F_7,78=10.32, P<0.001), although a non-significant reduction is observed. However, when tested using another vehicle (Vitamin E and glycofurol), osanetant does decrease activity significantly compare to Senktide-treated gerbils (F_2,30=10.10, P<0.001).

相关产品：Bioactive Compound Library Plus  |  Substance P  |  Aprepitant  |  Netupitant  |  Fosaprepitant dimeglumine  |  SB-222200  |  Maropitant  |  Vapreotide  |  Neurokinin A TFA  |  Neurokinin B TFA  |  Saredutant  |  Talnetant  |  Vofopitant  |  L-732138  |  NKP608  |  [Sar9,Met(O2)11]-Substance P TFA  |  Eprazinone dihydrochloride  |  Y1 receptor antagonist 1  |  Substance P(1-7) TFA  |  GR 159897  |  Men 10376 TFA  |  Neurokinin A(4-10) TFA  |  Osanetant

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。